The number of pharmacies throughout the United States is growing, but some populations may encounter barriers accessing them, according to researchers at the University of Illinois at Chicago.
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease. This finding was reported from a clinical trial conducted by researchers at Mayo Clinic and the National Cancer Institute, and published in the Journal of Clinical Oncology.
Hengbin Wang and colleagues describe a key role for a protein called RSF1 in silencing genes. Besides the molecular biology details, the researchers also showed that disruption of RSF1 expression in the embryos of African clawed frogs caused severe developmental defects in the tadpoles.
A study led by scientists at Harvard Medical School reveals that a gene that has a protective influence against diabetes is powerfully shaped by the trillions of intestinal bacteria collectively known as the gut microbiota.
Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in the August 30, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A research team led by Deborah Ellis, Ph.D., professor of family medicine and public health sciences in Wayne State University’s School of Medicine, received a $3.2 million award from the National Heart, Lung and Blood Institute of the National Institutes of Health. The grant will fund a study that will develop interventions to reduce barriers to optimal asthma management and reduce the risk for asthma-related deaths of minority children, with a focus on African American adolescents.
The therapy car invented at virginia mason to help orthopedic surgery patients practice the physical motions needed to get in and out of a real vehicle without falling is now licensed for commercial production and distribution to physical and occupational therapists anywhere in the world.
Changing from scheduled appointments to an "open gym" format can reduce waiting times for cardiac rehabilitation, reports a study in the September/October issue of Journal of Cardiopulmonary Rehabilitation and Prevention. The journal is published by Wolters Kluwer.
The University of Chicago Medicine is one of a limited number of U.S. sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the U.S. Food and Drug Administration.
Scientists may have found a clue to why people living with HIV have double the likelihood of developing heart disease. The findings, made by researchers at the University of Pittsburgh Center for Vaccine Research and National Institutes of Health, also show that an experimental drug may hold promise as a potential treatment.
Known for spending their work weeks hunched over their laptops and their weekends taking spin classes or playing video games, Millennials are prone to experiencing pain. However, a recent survey by the American Society of Anesthesiologists (ASA) reports that this generation is more likely to manage their pain in a natural way, without using opioids. Additional findings from the survey are in the news release below.
St. Jude Children’s Research Hospital is offering the global scientific community no-cost access to an unprecedented collection of pediatric solid tumor samples and data to fuel research and move treatment forward
HHMI Investigator Michael Dyer and colleagues are widely sharing data and samples from nearly 100 new tumor models representing 12 pediatric cancers.
Biomedical engineering researchers at Case Western Reserve University are refining more than 15 years of work on an electrical nerve-block implant, focusing their next step on new applications related to treating asthma and heart failure.
Mount Sinai Research Finds That When Making Decisions, Monkeys Use Different Brain Areas to Weigh Value and Availability
In a landmark decision for the field of cancer immunotherapy, the U.S. Food and Drug Administration (FDA) today approved a personalized cellular therapy developed by the University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP) for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
Study finds no one does well with less than seven hours of sleep; more than 11 hours suboptimal, too
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right